March 3, 2020 / 5:10 PM / a month ago

BRIEF-Mauna Kea Technologies Receives FDA Clearance For Its Cellvizio® Platform

March 3 (Reuters) - Mauna Kea Technologies SAS:

* MAUNA KEA TECHNOLOGIES RECEIVES FDA CLEARANCE AND CE MARKING FOR ITS NEXT-GENERATION CELLVIZIO® PLATFORM

* MAUNA KEA TECHNOLOGIES SAS SAYS NEW CELLVIZIO® PLATFORM INCLUDES SIGNIFICANT IMPROVEMENTS AND WILL ENABLE MAJOR INNOVATIONS

* MAUNA KEA TECHNOLOGIES SAS ANNOUNCED THAT IT HAS OBTAINED 510(K) CLEARANCE (K193416) FROM THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND CE MARKING OF CELLVIZIO® ENDOMICROSCOPY PLATFORM Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below